The Department of Health and Human Services’ Assistant Secretary for Preparedness and Response this week announced a major change in the distribution of COVID-19 monoclonal antibody therapies. As of Sept. 13, hospitals and other facilities administering monoclonal antibody therapies to COVID-19-positive patients must work through their state or territorial government to obtain those medications. 

Related News Articles

Headline
The Centers for Disease Control and Prevention yesterday released an operational planning guide for pediatric COVID-19 vaccination and preliminary information…
Headline
Available data support the safety and effectiveness of the Johnson & Johnson COVID-19 vaccine for emergency use authorization as a booster dose in…
Headline
A Food and Drug Administration advisory panel today voted unanimously to recommend an extra Moderna booster dose for certain individuals. The Vaccines and…
Headline
The AHA today launched a new video series, Vaccines Work, highlighting all the successful vaccines that have helped fight severe disease and illness, such as…
Headline
A new study released today by the National Academies of Sciences, Engineering and Medicine offers advice for communicating with parents about their children’s…
Headline
Food and Drug Administration staff provided their analysis of Johnson & Johnson’s COVID-19 booster application today, indicating that a second dose…